Goldman Sachs
ONCR

Goldman Sachs’s Oncorus, Inc. ONCR Stock Holding History

Goldman Sachs’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,195
Closed -$3.51K – 6219
2023
Q1 		$3.51K Sell
10,195
-6,994
-41% -$2.61K ﹤0.01% 5826
2022
Q4 		$4.35K Sell
17,189
-7,222
-30% -$4.11K ﹤0.01% 5823
2022
Q3 		$21K Sell
24,411
-93,514
-79% -$120K ﹤0.01% 5932
2022
Q2 		$148K Buy
117,925
+30,668
+35% +$41.7K ﹤0.01% 5740
2022
Q1 		$155K Sell
87,257
-20,429
-19% -$57.2K ﹤0.01% 5970
2021
Q4 		$568K Buy
107,686
+30,075
+39% +$233K ﹤0.01% 5289
2021
Q3 		$725K Sell
77,611
-89,437
-54% -$1.02M ﹤0.01% 4974
2021
Q2 		$2.31M Buy
167,048
+79,097
+90% +$1.22M ﹤0.01% 4076
2021
Q1 		$1.22M Buy
87,951
+73,434
+506% +$1.52M ﹤0.01% 4447
2020
Q4 		$469K Buy
+14,517
New +$336K ﹤0.01% 4643

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Goldman Sachs's ONCR Position: Q2 2023 in Review

Goldman Sachs sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 10,195 shares — an estimated $3.51K sold.

Goldman Sachs first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $2.31M in Q2 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Goldman Sachs reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 10,195 Oncorus, Inc. shares in Q2 2023, an estimated $3.51K.
  • Goldman Sachs first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • Goldman Sachs's Oncorus, Inc. position peaked at $2.31M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.